PROFUSEme: PROstate Cancer Biochemical Recurrence Prediction via FUSEd Multi-modal Embeddings

• URL: http://arxiv.org/abs/2509.14051v2
• Date: Sat, 20 Sep 2025 23:16:38 GMT
• Title: PROFUSEme: PROstate Cancer Biochemical Recurrence Prediction via FUSEd Multi-modal Embeddings
• Abstract summary: Almost 30% of prostate cancer (PCa) patients experience biochemical recurrence (BCR), characterized by increased prostate specific antigen (PSA) and associated with increased mortality.<n>We propose prostate cancer BCR prediction via fused multi-modal embeddings (PROFUSEme), which learns cross-modal interactions of clinical, radiology, and pathology data.
• Score: 2.83458288358676
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Almost 30% of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) experience biochemical recurrence (BCR), characterized by increased prostate specific antigen (PSA) and associated with increased mortality. Accurate early prediction of BCR, at the time of RP, would contribute to prompt adaptive clinical decision-making and improved patient outcomes. In this work, we propose prostate cancer BCR prediction via fused multi-modal embeddings (PROFUSEme), which learns cross-modal interactions of clinical, radiology, and pathology data, following an intermediate fusion configuration in combination with Cox Proportional Hazard regressors. Quantitative evaluation of our proposed approach reveals superior performance, when compared with late fusion configurations, yielding a mean C-index of 0.861 ($\sigma=0.112$) on the internal 5-fold nested cross-validation framework, and a C-index of 0.7107 on the hold out data of CHIMERA 2025 challenge validation leaderboard.

Related papers

• Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance [69.07885031885303]
  We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model.<n>It outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates.<n>In a multi-center cohort of 6,668 patients from 12 hospitals in China, HCC-STAR achieved state-of-the-art performance in treatment recommendation and risk stratification.
  arXiv  Detail & Related papers  (2026-07-09T15:33:08Z)
• A Pathology Foundation Model for Gastric Cancer with Real-World Validation [47.19073124722865]
  We present GRACE, a Gastric-specific foundation model for Real-world Assessment and Clinical dEcision support.<n> GRACE was developed from multicenter gastric pathology datasets totaling 48,364 primarily HE-stained whole-slide images from 37,493 patients.<n>When calibrated to maintain non-inferior performance to senior pathologists, the AI-assisted workflow could triage 60.7% of atrophy and 82.7% of intestinal metaplasia cases.
  arXiv  Detail & Related papers  (2026-06-03T12:18:06Z)
• Deep Learning From Routine Histology Improves Risk Stratification for Biochemical Recurrence in Prostate Cancer [2.499184782167909]
  We present a deep learning-based biomarker that predicts continuous, patient-specific risk of biochemical recurrence after radical prostatectomy.<n>When integrated with the CAPRA-S clinical risk score, the deep learning risk score consistently improved discrimination for BCR.
  arXiv  Detail & Related papers  (2026-03-15T02:22:38Z)
• Suppressing Prior-Comparison Hallucinations in Radiology Report Generation via Semantically Decoupled Latent Steering [94.37535002230504]
  We develop a training-free, inference-time control framework termed Semantically Decoupled Latent Steering.<n>Our approach constructs a semantic-free intervention vector via large language model (LLM)-driven semantic decomposition.<n>We show that our approach significantly reduces the probability of historical hallucinations.
  arXiv  Detail & Related papers  (2026-02-27T04:49:01Z)
• AI-based Prediction of Biochemical Recurrence from Biopsy and Prostatectomy Samples [0.012216782333971603]
  Biochemical recurrence (BCR) after radical prostatectomy is a surrogate marker for aggressive prostate cancer.<n>We trained an AI-based model on diagnostic prostate biopsy slides to predict patient-specific risk of BCR.
  arXiv  Detail & Related papers  (2026-01-28T20:33:15Z)
• Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy [0.0]
  The aim of this study is to evaluate the association between MRI descriptors and complete response (pCR) to neoadjuvant chemotherapy (NAC)<n>Unifocality and non-spiculated margins are independently associated with pCR and can increase models performance to predict BC response NAC.
  arXiv  Detail & Related papers  (2025-11-21T11:25:32Z)
• ModalSurv: A Multimodal Deep Survival Framework for Prostate and Bladder Cancer [5.509924404430891]
  We present ModaliSurv, a multimodal deep survival model utilising DeepHit with a projection layer and inter-modality cross-attention.<n>The model is designed to capture complementary prognostic signals across modalities and estimate individualised time-to-biochemical recurrence.
  arXiv  Detail & Related papers  (2025-09-05T11:52:53Z)
• LGE-Guided Cross-Modality Contrastive Learning for Gadolinium-Free Cardiomyopathy Screening in Cine CMR [51.11296719862485]
  We propose a Contrastive Learning and Cross-Modal alignment framework for gadolinium-free cardiomyopathy screening using cine CMR sequences.<n>By aligning the latent spaces of cine CMR and Late Gadolinium Enhancement (LGE) sequences, our model encodes fibrosis-specific pathology into cine CMR embeddings.
  arXiv  Detail & Related papers  (2025-08-23T07:21:23Z)
• Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images [2.23127246021293]
  Triple-negative breast cancer (TNBC) remains a major clinical challenge due to its aggressive behavior and lack of targeted therapies.<n>We present an attention-based multiple instance learning framework designed to predict pathologic complete response (pCR) directly from pre-treatment hematoxylin and eosin (H&E)-stained biopsy slides.
  arXiv  Detail & Related papers  (2025-05-20T02:06:34Z)
• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Prediction of Breast Cancer Recurrence Risk Using a Multi-Model Approach Integrating Whole Slide Imaging and Clinicopathologic Features [0.6679306163028237]
  The aim of this study was to develop a multi-model approach integrating the analysis of whole slide images and clinicopathologic data to predict associated breast cancer recurrence risks. The proposed novel methodology uses convolutional neural networks for feature extraction and vision transformers for contextual aggregation.
  arXiv  Detail & Related papers  (2024-01-28T23:33:56Z)
• Penalized Deep Partially Linear Cox Models with Application to CT Scans of Lung Cancer Patients [42.09584755334577]
  Lung cancer is a leading cause of cancer mortality globally, highlighting the importance of understanding its mortality risks to design effective therapies. The National Lung Screening Trial (NLST) employed computed tomography texture analysis to quantify the mortality risks of lung cancer patients. We propose a novel Penalized Deep Partially Linear Cox Model (Penalized DPLC), which incorporates the SCAD penalty to select important texture features and employs a deep neural network to estimate the nonparametric component of the model.
  arXiv  Detail & Related papers  (2023-03-09T15:38:16Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• Exploiting segmentation labels and representation learning to forecast therapy response of PDAC patients [60.78505216352878]
  We propose a hybrid deep neural network pipeline to predict tumour response to initial chemotherapy. We leverage a combination of representation transfer from segmentation to classification, as well as localisation and representation learning. Our approach yields a remarkably data-efficient method able to predict treatment response with a ROC-AUC of 63.7% using only 477 datasets in total.
  arXiv  Detail & Related papers  (2022-11-08T11:50:31Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.